Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Heartflow (HTFL) Change in Accured Expenses (2024 - 2025)

Heartflow has reported Change in Accured Expenses over the past 2 years, most recently at $3.4 million for Q4 2025.

For Q4 2025, Change in Accured Expenses rose 1.91% year-over-year to $3.4 million; the TTM value through Dec 2025 reached $16.9 million, changed N/A, while the annual FY2025 figure was $9.3 million, 2086.15% up from the prior year.
Change in Accured Expenses for Q4 2025 was $3.4 million at Heartflow, down from $6.2 million in the prior quarter.
Over five years, Change in Accured Expenses peaked at $6.2 million in Q3 2025 and troughed at $3.3 million in Q4 2024.